Medical polymer with the same properties and performance as PLLA polymer.
"Poly-D-lactic acid (PDLA)" is obtained by using lactide (the cyclic dimer of lactic acid) as a monomer and performing ring-opening polymerization. It has the same properties and performance as PLLA polymer and can be substituted for PLLA, so it is rarely used alone. When PLLA and stereo complex (scPLA) are formed, phenomena such as an increase in melting point and improvement in mechanical properties occur, leading to ongoing research and development of scPLA. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. [Features] ■ Has the same properties and performance as PLLA polymer ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Crystallinity, transparency, heat resistance (when stereo complexed) *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Polymer Identification: Must match the IR spectrum of standard PDLA ■ Molecular Weight (MW): MW = 200,000 − 280,000 ■ Melting Point (Tm): Tm = 180 − 195 (℃) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm * This is the specification for our representative PDLA polymer. * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Applications】 ■ Thread (single thread, braided cord, mesh) ■ Film ■ Membrane ■ Blocks (screws, etc.): bone fixation materials ■ Others: new medical devices *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Institute for Frontier Medical Sciences at Kyoto University. Since its founding, the company has focused on the field of medical polymers to realize its corporate philosophy of "contributing to the health of people around the world by working on the development of better medical biomaterial products and providing innovative solutions in the medical field," supporting advancements in biomaterials technology and people's health across three business areas.